Health care policy and community pharmacy: Implications for the New Zealand primary health care sector

New Zealand Medical Journal

Volumn 123, Issue 1317, 2010, Pages

  Scahill, Shane ^a   Harrison, Jeff ^b   Carswell, Peter ^b   Shaw, John ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL SERVICE; NEW ZEALAND; PATIENT CARE; PHARMACY; PRIMARY HEALTH CARE; REVIEW; ARTICLE; COOPERATION; HUMAN; ORGANIZATION AND MANAGEMENT; PUBLIC RELATIONS;

COOPERATIVE BEHAVIOR; HEALTH CARE REFORM; HEALTH POLICY; HUMANS; INTERPROFESSIONAL RELATIONS; NEW ZEALAND; PHARMACIES; PRIMARY HEALTH CARE;

EID: 77954296962     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Gilbert L. Pharmacy's attempts to extend its roles: case study in South Africa. Soc Sci & Med 1998;47(2):153-164.
2. Dept of Health (UK). Pharmacy in England: Building on Strengths - Delivering the Future. Her Majesty's Government, Dept of Health Publications, London; 2008.
3. Galbraith A. Review of NHS Pharmaceutical Contractual Arrangements: Report for the Dept of Health, London; 29 March 2007.
4. Ministry of Health. Medicines New Zealand. Wellington, New Zealand; 2007.
5. Pharmaceutical Society of New Zealand. Focus on the Future: Ten Year Vision for Pharmacists': 2004-2014. Wellington; 2004.
6. Bryant L. Evaluation of the barriers to and implementation of comprehensive pharmaceutical care in New Zealand. PhD thesis: University of Auckland; 2006.
7. Ministry of Health. New Zealand Primary Health Care Strategy. Wellington, New Zealand; 2001.
8. Blenkinsopp A, Celino G, Bond C, Inch J. Medicines use reviews: the first year of a new community pharmacy service. Pharm J 2007;278(7440):218-223. (Pubitemid 46381047)
9. Anderson C, Blenkinsopp A, Armstrong M. The contribution of community pharmacy to improving the public's health: Evidence from the peer-reviewed literature of 1990-2001. Available at http://www.pharmacyhealthlink.org.uk. Accessed 12 Jan 2009.
10. PharmacyHealthLink and Royal Pharmaceutical Society of Great Britain. London, 2003. Anderson C, Blenkinsopp A, Armstrong M. The contribution of community pharmacy to improving the public's health. Evidence from the peer reviewed literature 2001-2004. Available at http://www.pharmacyhealthlink.org. uk/ Accessed 12 Jan 2009. Pharmacy HealthLink and Royal Pharmaceutical Society of Great Britain. London, 2005.
11. Dept of Health (UK). Pharmacy in the future: a vision for pharmacy in the new NHS. Dept of Health Publications. London; July 2000.
12. Dept of Health (UK). A Vision For Pharmacy in the New NHS. Dept of Health Publications, London; July 2003.
13. Government of Australia. The Fourth Community Pharmacy Agreement. Commonwealth Government of Australia. Canberra; 2005.
14. Canadian Pharmacists' Association. Blueprint for Pharmacy. Edmonton, Canada; 2007.
15. United States Government. Pharmacy Affairs and 340B Drug Pricing Program. US Dept of Health and Human Services; Rockville, MD, 2008.
16. Ministry of Health. Primary Health Care Strategy: Implementation Work Programme 2005- 2010. New Zealand Ministry of Health. Wellington, New Zealand; 2006.
17. Ministry of Health. Minimum Requirements for PHO's. New Zealand Ministry of Health. Wellington, New Zealand; 2001.
18. Sanchez R, Heene A. The New Strategic Management: Organisation, Competition and Competence. New York: John Wiley & Sons, Inc; 2004.
19. Scahill S, Harrison J, Sheridan J. Pharmacy under the spotlight: New Zealand pharmacist's perceptions of roles and accreditation. Int J Pharm Pract 2010;(18):59-62
20. Celino G, Blenkinsopp A, Dhalla M. Pharmaceutical Needs Assessment Toolkit. UK National Health Service. London; 2004.
21. Elvey R, Bradley F, Ashcroft D, Noyce P. Commissioning services and the new community pharmacy contract: (4) Governance and performance management. Pharm J 2006;277(7415):251-253.
22. Hall J, Smith I. Barriers to medicines use reviews: Comparing the views of pharmacists and PCTs. Int J Pharm Pract 2006(Suppl 2):B51-B52.
23. Bush J, Langley CA, Jesson JK, Wilson KA. Perceived barriers to the development of community pharmacy's public health function: a survey of the attitudes of Directors of Public Health and Chief Pharmacists in UK primary care organisations. Int J Pharm Pract 2006;Suppl 2:B68-B69.
24. Walker R. Pharmaceutical Public Health: the end of pharmaceutical care? Pharm J 2000;264:340-1.
25. Scahill S, Harrison J, Sheridan J. The ABC of New Zealand's Ten Year Vision for Pharmacists: Awareness, Barriers and Culture. Int J of Pharm Pract 2009;17:135-142.
26. Tsuyuki R, Schindel TJ. Leading Change in Pharmacy Practice: Fully Engaging Pharmacists in Patient-Oriented Healthcare. COMPRIS, University of Alberta, Edmonton; 2004.
27. Anderson C., Blenkinsopp A., Armstrong M. The contribution of community pharmacy to improving the public's health: Literature review update 2004-2007. Available at http://www.pharmacyhealthlink.org.uk Accessed 12 Jan 2009. PharmacyHealthLink and Royal Pharmaceutical Society of Great Britain. London; 2008.
28. Holdford D, Kennedy DT, Bernadella P, Small RE. Implementing disease management in community pharmacy practice. Clin Therap 1998;20(2):328-339.